Anti-IGF1R Neutralizing Antibody (V3S-0622-YC4575) (CAT#: V3S-0622-YC4575)

Send Inquiry
  • fig1
    Figure 1 Anti-Human IGF1R Monoclonal Antibody (V3S-0622-YC4575) in SDS-PAGE
  • fig1
    Figure 2 Anti-Human IGF1R Monoclonal Antibody (V3S-0622-YC4575) in SEC-HPLC
  • fig1
    Figure 3 Anti-Human IGF1R Monoclonal Antibody (V3S-0622-YC4575) in ELISA

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description This product is a human monoclonal antibody that reacts with IGF1R. The antibody is expressed with mammalian cell transient expression system, serum-free and purified by affinity chromatography. The purity and integrity are tested via SDS-PAGE and SEC-HPLC analysis. Given an antigen, additional QC measures are also desired such as affinity testing and binding validation.
Specifically, the antibody is provided in multiple formats for in vivo and in vitro assays. The Invivo version features greater than 95% purity, ultra-low endotoxin levels (<1 EU/mg or 0.1 EU/mg), and is preservative, stabilizer, and carrier protein-free.
Clonality Monoclonal
Host Species Human
Target Species Human
Isotype IgG

Property

Expression Species HEK293F or CHO
Conjugation None
Purity >95%, determined by SDS-PAGE and/or SEC-HPLC
Endotoxin <1 EU/mg, determined by LAL method
Purification Protein A affinity purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4⁰C within a week. For longer storage, aliquot and store at -20⁰C.

Applications

Application FC; IP; ELISA; Neut; FuncS; IF; ICC
Application Notes The antibody is recommended for detection of IGF1R by FC, IP, ELISA, Neut, FuncS, IF, ICC assays.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target IGF1R
Alternative Name IGF1R; insulin-like growth factor 1 receptor; IGFR; CD221; IGFIR; JTK13; IGF-I receptor; soluble IGF1R variant 1; soluble IGF1R variant 2; insulin-like growth factor I receptor
Gene ID 3480
UniProt P08069
Research Area Signal Pathway; Cancer Research

Tested Data

SDS-PAGE

Figure 1 Anti-Human IGF1R Monoclonal Antibody (V3S-0622-YC4575) in SDS-PAGE

SDS-PAGE analysis of V3S-0622-YC4575 in non-reduced (lane 1) and β-mercaptoethanol-reduced (lane 2) conditions. Gel stained for 30 minutes with Coomassie Blue. As a result of different β-mercaptoethanol-reduced proteins (Heavy chain and Light chain) migrate as about 50 kDa and 25 kDa, respectively. And non-reduced protein migrates as 130-180 kDa.

Figure 1 Anti-Human IGF1R Monoclonal Antibody (V3S-0622-YC4575) in SDS-PAGE

HPLC

Figure 2 Anti-Human IGF1R Monoclonal Antibody (V3S-0622-YC4575) in SEC-HPLC

The purity of V3S-0622-YC4575 was greater than 95% as determined by SEC-HPLC.

Column: 3 µm, 7.8 x 300 nm
Mobile phase: 150 mM Sodium Phosphate Buffer, pH 7.0
Detection: UV 280 nm
Injection: 10 µl

Figure 2 Anti-Human IGF1R Monoclonal Antibody (V3S-0622-YC4575) in SEC-HPLC

ELISA

Figure 3 Anti-Human IGF1R Monoclonal Antibody (V3S-0622-YC4575) in ELISA

ELISA analysis of V3S-0622-YC4575 was performed by coating with recombinant IGF1R protein (50 ng/mL). Then blocked with BSA, and incubated with IGF1R Antibody, V3S-0622-YC4575. The HRP-conjugated goat anti-human IgG as a secondary antibody. Detection was performed using TMB substrate and stopped with sulfuric acid. The absorbances were read on a spectrophotometer at 450 nm.

Figure 3 Anti-Human IGF1R Monoclonal Antibody (V3S-0622-YC4575) in ELISA

For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
Online Inquiry